Sigma 1 receptor agonists: the new trend or an emerging therapeutic option?

1. Since its identification in the late 1970s as a putative subtype of opioid receptor, the sigma-1 (σ1) receptor has emerged as a highly distinctive pharmacological target. Initially reclassified ...

Authors

Institutions

Publication Details

Journal
Expert Opinion on Emerging Drugs
Published
2026-06-29
DOI
https://doi.org/10.1080/14728214.2026.2696872
Primary Topic
Pharmacological Receptor Mechanisms and Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sigma 1 receptor agonists: the new trend or an emerging therapeutic option?

Tangui Maurice
Expert Opinion on Emerging Drugs
Pharmacological Receptor Mechanisms and Effects
article

Sigma 1 receptor agonists: the new trend or an emerging therapeutic option?

Tangui Maurice
article en

Abstract

1. Since its identification in the late 1970s as a putative subtype of opioid receptor, the sigma-1 (σ1) receptor has emerged as a highly distinctive pharmacological target. Initially reclassified ...

Expert Opinion on Emerging Drugs
Inserm (FR), Université de Montpellier (FR), Institute for Neurosciences of Montpellier (FR)
Openalex Percentile: Top 11%
Pharmacological Receptor Mechanisms and Effects
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Sigma 1 receptor agonists: the new trend or an emerging therapeutic option? — Tangui Maurice · Expert Opinion on Emerging Drugs (2026) | TGRS Research Map | TGRS